These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31618438)

  • 1. Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases.
    Gulli F; Napodano C; Marino M; Ciasca G; Pocino K; Basile V; Visentini M; Stefanile A; Todi L; De Spirito M; Rapaccini GL; Basile U
    Clin Exp Immunol; 2020 Feb; 199(2):163-171. PubMed ID: 31618438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
    Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
    Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of immunoglobulin free light chains in patients with chronic hepatitis C presenting cryoglobulinemia.
    Oliveira IS; Cabral MS; Jesus LS; Paraná R; Atta AM; Sousa Atta ML
    Braz J Infect Dis; 2014; 18(6):638-42. PubMed ID: 25193081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
    Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
    Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases.
    Wei Q; Jiang Y; Xie J; Lv Q; Xie Y; Tu L; Xiao M; Wu Z; Gu J
    J Clin Lab Anal; 2020 Dec; 34(12):e23546. PubMed ID: 33047841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum free light chains for monitoring systemic lupus erythematosus activity].
    Żychowska I; Suszek D; Dryglewska M; Nurzyńska D; Donica H; Majdan M
    Wiad Lek; 2018; 71(1 pt 1):21-31. PubMed ID: 29558348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study.
    Sandhya P; Christudoss P; Kabeerdoss J; Mandal SK; Aithala R; Mahasampath G; Job V; Danda D
    Int J Rheum Dis; 2017 Jun; 20(6):760-766. PubMed ID: 28036132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
    Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
    Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
    Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
    Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu.
    Bosello S; Basile U; De Lorenzis E; Gulli F; Canestrari G; Napodano C; Parisi F; Pocino K; Di Mario C; Tolusso B; Ferraccioli G; Gremese E
    J Clin Pathol; 2018 Jul; 71(7):620-625. PubMed ID: 29447111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity.
    Gigante A; Pellicano C; Leodori G; Napodano C; Vantaggio L; Gulli F; Marino M; Visentini M; Rosato E; Basile U
    Clin Exp Immunol; 2021 Aug; 205(2):135-141. PubMed ID: 33934349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment.
    Basile U; Gragnani L; Piluso A; Gulli F; Urraro T; Dell'Abate MT; Torti E; Stasi C; Monti M; Rapaccini GL; Zignego AL
    Liver Int; 2015 Sep; 35(9):2100-7. PubMed ID: 25800731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance and predictive value of free light chains in the urine of patients with chronic inflammatory rheumatic disease.
    Bramlage CP; Froelich B; Wallbach M; Minguet J; Grupp C; Deutsch C; Bramlage P; Koziolek M; Müller GA
    Clin Rheumatol; 2016 Dec; 35(12):2939-2946. PubMed ID: 27734231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical validation of new ELISAs for the quantitation of polyclonal free light chains and comparison to existing assays for healthy and patient samples.
    Heaney JLJ; Campbell JP; Goodall M; Plant T; Shemar M; Hand C; Drayson MT
    J Immunol Methods; 2020 Mar; 478():112713. PubMed ID: 31783021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia.
    Basile U; Marino M; Gragnani L; Napodano C; Gulli F; Pocino K; Lorini S; Santini SA; Basile V; Miele L; Zignego AL; Rapaccini GL
    J Immunol Methods; 2020 Jan; 476():112687. PubMed ID: 31669506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia.
    Basile U; Gulli F; Napodano C; Pocino K; Basile V; Marrapodi R; Colantuono S; Todi L; Marino M; Rapaccini GL; Visentini M
    Biotechnol Appl Biochem; 2021 Apr; 68(2):319-329. PubMed ID: 32333692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.
    Bradwell AR; Carr-Smith HD; Mead GP; Tang LX; Showell PJ; Drayson MT; Drew R
    Clin Chem; 2001 Apr; 47(4):673-80. PubMed ID: 11274017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients.
    Bourguignon C; Chenine L; Bargnoux AS; Leray-Moragues H; Canaud B; Cristol JP; Morena M
    J Nephrol; 2016 Apr; 29(2):251-257. PubMed ID: 26022721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases.
    Bettacchioli E; Le Gaffric C; Mazeas M; Borghi MO; Frostegard J; Barturen G; Makowska Z; Babei S; Lesche R; ; Meroni PL; Alarcon-Riquelme ME; Renaudineau Y
    J Transl Autoimmun; 2021; 4():100090. PubMed ID: 33817614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of serum free light chain levels in healthy adults immediately after marathon running.
    Campbell JP; Eijsvogels TM; Wang Y; Hopman MT; Jacobs JF
    Clin Chem Lab Med; 2016 Mar; 54(3):459-65. PubMed ID: 26351935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.